Diligence memo · auto-generated · as of July 2, 2026
Synata Bio, Inc.
Synata Bio, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Synata Bio, Inc. operates in Other Energy, based in WARRENVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Synata Bio, Inc. has raised $78M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $47M on 2016-12-05.
Most recent recorded round closed around 2019-10-17.
Valuation (modeled)modeled
Provath models Synata Bio, Inc. at approximately $7.3M (range $2.2M–$19M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.01× the median modeled value of Series C Other Energy companies in 2019–2021 (12 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 6.7 yr ago; this sector typically re-raises about every 12 months.
Silent for over 3× the sector's normal cadence.
The last round was 77.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 93% of Other Energy peers (2049 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: Redaptive, Inc., Envoy Power Inc., VoltaGrid LLC, SR Finco, LLC, NGV Global Group Inc.
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.